PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Prostate cancer treatment is advancing rapidly. New pills and hormone treatments are giving patients better odds and a more comfortable experience. Doctors say Biden's diagnosis is a reminder to get ...

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and PDIA5, to survive and resist treatment. When these enzymes are blocked, cancer ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

NEW YORK (Reuters Health) - Men diagnosed with localized prostate cancer are more likely to be treated with proton beam therapy, a novel form of radiation therapy, if the technology is available ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment. Dr. Daniel P. Petrylak, a professor of Medicine ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

The long-term outlook for men diagnosed with prostate cancer continues to improve. About 98% are living for 10 years or more after diagnosis, and the survival rate at 15 years now exceeds 95%. These ...

The former PM is calling for more men to be screened for the disease, which is the most common cancer in males in the UK.